Cor Vasa 2022, 64(6):619-621 | DOI: 10.33678/cor.2022.023

The journey of a patient with ACTA2 mutation - literature review and case report

Ivo Petrova, Assen Keltchevb, Zoran Stankova, Strahil Vasilev
a Cardiology and Angiology Department, Acibadem CityClinic, Sofia University Hospital, Bulgaria
b Cardiac Surgery Department, Acibadem CityClinic, Sofia University Hospital, Bulgaria

Aortic pathologies are a main part of the cardiovascular disease specter. ACTA2 mutation is the main cause of familial thoracic aortic aneurysms and dissection, which is presented by dilation or dissection of the thoracic aorta in people, who do not have systemic or syndromic connective tissue disorder. The ACTA2 gene encodes the specific α-smooth muscle actin, which is an isoform of vascular smooth muscle actin. This mutation mainly leads to aortic pathologies, but it also presents a multisystemic smooth muscle dysfunction. We present a patient with typical clinical findings, consistent with an ACTA2 mutation and the treatment outcomes after consecutive endovascular and surgical interventions. The presentation and the evolution of the clinical symptoms of our patient closely follow the description of the disease in the literature.

Keywords: ACTA2, Aortic dissection, Marfan syndrome, Mutation

Received: November 18, 2021; Revised: March 3, 2022; Accepted: March 8, 2022; Published: December 15, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Petrov I, Keltchev A, Stankov Z, Vasilev S. The journey of a patient with ACTA2 mutation - literature review and case report. Cor Vasa. 2022;64(6):619-621. doi: 10.33678/cor.2022.023.
Download citation

References

  1. Morisaki H, Akutsu K, Ogino H, et al. Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD). Hum Mutat 2009;30:1406-1411. Go to original source... Go to PubMed...
  2. Regalado ES, Guo DC, Prakash S, et al. Aortic Disease Presentation and Outcome Associated With ACTA2 Mutations. Circ Cardiovasc Genet 2015;8:457-464. Go to original source... Go to PubMed...
  3. Wolford BN, Hornsby WE, Guo D, et al. Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection. Circ Genom Precis Med 2019;12:e002476. Go to original source...
  4. Dominguez R, Holmes KC. Actin structure and function. Annu Rev Biophys 2011;40:169-186. Go to original source... Go to PubMed...
  5. Guo DC, Pannu H, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections [published correction appears in Nat Genet 2008;40:255]. Nat Genet 2007;39:1488-1493. Go to original source... Go to PubMed...
  6. Yuan SM. α-Smooth Muscle Actin and ACTA2 Gene Expressions in Vasculopathies. Braz J Cardiovasc Surg 2015;30:644-649. Go to original source... Go to PubMed...
  7. Keravnou A, Bashiardes E, Michailidou K, et al. Novel variants in the ACTA2 and MYH11 genes in a Cypriot family with thoracic aortic aneurysms: a case report. BMC Med Genet 2018;19:208. Go to original source... Go to PubMed...
  8. Disabella E, Grasso M, Gambarin FI, et al. Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2). Heart 2011;97:321-326. Go to original source... Go to PubMed...
  9. Petrov I, Kaneva-Nencheva A, Levunlieva E, et al. Successful endovascular treatment of type B aortic dissection in a 15-year-old child. Cor Vasa 2017;59:e163-e170. Go to original source...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.